Consider that patients with rheumatoid arthritis or Crohn's disease under TNF-blocking therapies can develop autoantibodies to nuclear antigens [34]; therapeutic TNF blockades could thus lead to an exacerbation of certain autoimmune diseases such as SLE and to provoke lupus-like manifestations. The gene discussed is TNF; the disease is systemic lupus erythematosus.